The effect of geniposide on chronic unpredictable mild stress-induced depressive mice through BTK/TLR4/NF-κB and BDNF/TrkB signaling pathways
- PMID: 33164233
- DOI: 10.1002/ptr.6846
The effect of geniposide on chronic unpredictable mild stress-induced depressive mice through BTK/TLR4/NF-κB and BDNF/TrkB signaling pathways
Abstract
The purpose of this study was to estimate the pharmacological effect of geniposide (GEN) on depression, caused by chronic unpredictable mild stress (CUMS), and explore its potential mechanism. During the 6 week CUMS procedure, the mice were treated with GEN (10, 40 mg/kg) by gavage once daily for 3 weeks. As a result, the GEN treatment remarkably improved the behavioral manifestations and suppressed the generations of inflammatory cytokines both in vivo and in vitro. The MDA level was significantly increased, while the activities of SOD, GSH-PX were decreased in CUMS-challenged mice and corticosterone-stimulated PC12 cells. GEN administration significantly inhibited those changes. Moreover, GEN treatment could downregulate the expressions of p-BTK, TLR4, MyD88, p-NF-κB proteins, and upregulate BDNF, p-TrkB generations in CUMS-induced mice. Moreover, GEN administration inhibited the protein levels of p-BTK, TLR4, MyD88, p-NF-κB in corticosterone-induced PC12 cell. In summary, the results suggested that GEN exerted a therapeutic effect on CUMS-induced depressive mice possibly through the regulation of BTK/TLR4/NF-κB and BDNF/TrkB signaling pathways.
Keywords: BDNF/TrkB pathway; BTK/TLR4/NF-κB pathway; CUMS; Geniposide; PC12 cells; depression.
© 2020 John Wiley & Sons Ltd.
Similar articles
-
The protective effect of Geniposide on diabetic cognitive impairment through BTK/TLR4/NF-κB pathway.Psychopharmacology (Berl). 2020 Feb;237(2):465-477. doi: 10.1007/s00213-019-05379-w. Epub 2019 Dec 6. Psychopharmacology (Berl). 2020. PMID: 31811349
-
Geniposide protects depression through BTK/JAK2/STAT1 signaling pathway in lipopolysaccharide-induced depressive mice.Brain Res Bull. 2021 May;170:65-73. doi: 10.1016/j.brainresbull.2021.02.008. Epub 2021 Feb 6. Brain Res Bull. 2021. PMID: 33561536
-
The antidepressant effects of hesperidin on chronic unpredictable mild stress-induced mice.Eur J Pharmacol. 2019 Jun 15;853:236-246. doi: 10.1016/j.ejphar.2019.03.035. Epub 2019 Mar 28. Eur J Pharmacol. 2019. PMID: 30928632
-
Anti-Depressive Effectiveness of Baicalin In Vitro and In Vivo.Molecules. 2019 Jan 17;24(2):326. doi: 10.3390/molecules24020326. Molecules. 2019. PMID: 30658416 Free PMC article.
-
The role of medicinal products in the treatment of inflammatory bowel diseases (IBD) through inhibition of TLR4/NF-kappaB pathway.Phytother Res. 2021 Feb;35(2):835-845. doi: 10.1002/ptr.6866. Epub 2020 Sep 14. Phytother Res. 2021. PMID: 32929778 Review.
Cited by
-
The relevance between abnormally elevated serum ceramide and cognitive impairment in Alzheimer's disease model mice and its mechanism.Psychopharmacology (Berl). 2024 Mar;241(3):525-542. doi: 10.1007/s00213-024-06530-y. Epub 2024 Jan 26. Psychopharmacology (Berl). 2024. PMID: 38277004
-
Role of BDNF-TrkB signaling in the antidepressant-like actions of loganin, the main active compound of Corni Fructus.CNS Neurosci Ther. 2023 Dec;29(12):3842-3853. doi: 10.1111/cns.14305. Epub 2023 Jul 5. CNS Neurosci Ther. 2023. PMID: 37408379 Free PMC article.
-
Therapeutic potential of plant iridoids in depression: a review.Pharm Biol. 2022 Dec;60(1):2167-2181. doi: 10.1080/13880209.2022.2136206. Pharm Biol. 2022. PMID: 36300881 Free PMC article. Review.
-
The protective effect of Palmatine on depressive like behavior by modulating microglia polarization in LPS-induced mice.Neurochem Res. 2022 Oct;47(10):3178-3191. doi: 10.1007/s11064-022-03672-3. Epub 2022 Aug 2. Neurochem Res. 2022. PMID: 35917005
-
Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression.J Neuroinflammation. 2022 Jun 6;19(1):132. doi: 10.1186/s12974-022-02492-0. J Neuroinflammation. 2022. PMID: 35668399 Free PMC article. Review.
References
REFERENCES
-
- Bai, Y. Y., Ruan, C. S., Yang, C. R., Li, J. Y., Kang, Z. L., Zhou, L., … Zhou, X. F. (2016). ProBDNF signaling regulates depression-like behaviors in rodents under chronic stress. Neuropsychopharmacology, 41(12), 2882-2892.
-
- Bharti, V., Tan, H., Deol, J., Wu, Z., & Wang, J. F. (2020). Upregulation of antioxidant thioredoxin by antidepressants fluoxetine and venlafaxine. Psychopharmacology, 237(1), 127-136.
-
- Chu, C., Wei, H., Zhu, W., Shen, Y., & Xu, Q. (2017). Decreased prostaglandin D2 levels in major depressive disorder are associated with depression-like behaviors. The International Journal of Neuropsychopharmacology, 20(9), 731-739.
-
- Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., … Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. Lancet, 391(10128), 1357-1366.
-
- Colasanti, A., Guo, Q., Giannetti, P., Wall, M. B., Newbould, R. D., Bishop, C., … Rabiner, E. A. (2016). Hippocampal neuroinflammation, functional connectivity, and depressive symptoms in multiple sclerosis. Biological Psychiatry, 80(1), 62-72.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
